Suffolk University unveils its top 5 and bottom 5 for the 2025 USA TODAY Ad Meter Marketing Spotlight. See which Super Bowl ...

Hims & Hers Health, Inc. stock surged 1,000% with strategic growth, but high valuation & short interest suggest taking ...

The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime.

The Super Bowl aired a Hims & Hers commercial that is receiving backlash for its non-FDA approved weight loss drug. This drug ...

Highlights,Hims & Hers Health operates in the expanding digital healthcare sector, focusing on telehealth services and ...

Hims & Hers Health's (NYSE: HIMS) share price has surged recently, climbing above $60 and creating new 52-week and all-time ...

Several companies rightfully used the heavily sought-after screen time to raise awareness and send powerful messages, and it ...

Yeezy isn’t the only company being called out for its “bait-and-switch” Super Bowl commercial, a Californian company called ...